New hope for advanced liver disease? study tests common heart drug combo
NCT ID NCT06764966
Summary
This study is testing if adding a cholesterol-lowering statin drug to standard beta blocker treatment can help control advanced liver disease (decompensated cirrhosis). It will enroll 50 patients who already have serious liver complications. The goal is to see if this combination is safe, practical, and can prevent the disease from getting worse over 12 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charleston Area Medical Center
RECRUITINGCharleston, West Virginia, 25304, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.